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Background: Abdominal aortic aneurysm (AAA) disease is an insidious condition with an 85% chance of death after
rupture. Ultrasound screening can reduce mortality, but its use is advocated only for a limited subset of the population
at risk.
Methods: We used data from a retrospective cohort of 3.1 million patients who completed a medical and lifestyle
questionnaire and were evaluated by ultrasound imaging for the presence of AAA by Life Line Screening in 2003 to 2008.
Risk factors associated with AAA were identified using multivariable logistic regression analysis.
Results: We observed a positive association with increasing years of smoking and cigarettes smoked and a negative
association with smoking cessation. Excess weight was associated with increased risk, whereas exercise and consumption
of nuts, vegetables, and fruits were associated with reduced risk. Blacks, Hispanics, and Asians had lower risk of AAA than
whites and Native Americans. Well-known risk factors were reaffirmed, including male gender, age, family history, and
cardiovascular disease. A predictive scoring system was created that identifies aneurysms more efficiently than current
criteria and includes women, nonsmokers, and individuals aged<65 years. Using this model on national statistics of risk
factors prevalence, we estimated 1.1 million AAAs in the United States, of which 569,000 are among women,
nonsmokers, and individuals aged <65 years.
Conclusions: Smoking cessation and a healthy lifestyle are associated with lower risk of AAA.We estimated that about half
of the patients with AAA disease are not eligible for screening under current guidelines. We have created a high-yield
screening algorithm that expands the target population for screening by including at-risk individuals not identified with
existing screening criteria. ( J Vasc Surg 2010;52:539-48.)Rupture of abdominal aortic aneurysm (AAA) is a high
mortality event and usually the first and only clinical man-
ifestation of aneurysmal dilatation of the abdominal aorta.1
The in-hospital survival rate for treating a ruptured AAA
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opportunity for surgical intervention.2 Aortic aneurysms
result in at least 14,000 deaths per year in the United
States.3 This number is likely an underestimation, because
approximately 5% of the 200,000 people who die of sudden
death each year may have AAA as the cause.4
AAAs can be detected noninvasively and relatively in-
expensively through ultrasound imaging, which has a sen-
sitivity and specificity of nearly 100% for this disorder.5
Early detection of AAA can be life-saving, giving patients
the opportunity to undergo elective surgical repair, a much
safer and effective intervention than emergency repair after
rupture. The United States Preventive Services Task Force
(USPSTF) has recommended AAA screening for men aged
65 to 75 years with a history of smoking6 because of the
high prevalence of AAA in this population and the demon-
strated reduction in AAA-related mortality among those
who have been screened.7-10 However, at least 33% of
ruptured AAA hospitalizations and 41% of aortic aneurysm
deaths are among women, and 22% of AAA-related deaths
occur in nonsmokers.11-13 For these groups, screening has
received a grade D (against) or C (neutral recommenda-
tion), respectively, by the USPSTF. Thus, current national
guidelines for AAA screening fail to target some of the
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deaths occur.
Given the incidence of AAA deaths in women and
nonsmokers, a reassessment of the benefits of screening is
needed in these populations to determine whether high-
risk subpopulations can be identified for targeted screen-
ing. Analyzing a cohort of 3.1 million men and women of
different racial and ethnic backgrounds, we generated a
robust multivariable model for risk stratification. We de-
rived a scoring system from this model and applied it to a
detailed independently collected representative national
data set to estimate the prevalence of AAA nationwide and
address the potential benefits of upgrading selection criteria
for screening.
METHODS
Source of data. The AAA screening database was
provided by Life Line Screening Inc (LLS, Independence,
Ohio) to the Society for Vascular Surgery for purposes of
research. The study cohort consists primarily of self-
referred individuals who paid for the test out of pocket.
Screenings were performed in 20,000 screening sites
nationwide. Before screening, individuals complete a 36-
item questionnaire including demographics, height and
weight, coronary artery disease (previous myocardial infarc-
tion or a history of coronary revascularization), cerebrovas-
cular disease (previous transient ischemic attack, stroke, or
carotid artery revascularization), hypertension, hypercho-
lesterolemia, diabetes, past revascularizations of coronary,
carotid, and lower extremities arteries; and smoking, exer-
cise, dietary habits, and family medical history (first-degree
relative diagnosed with AAA, lower extremity arterial dis-
ease, cardiac, or cerebrovascular disease).
Hypertension, hypercholesterolemia, or diabetes were
deemed present if diagnosed by a physician or controlled
with medications, or both. Systolic blood pressure was
measured in both upper extremities using Doppler tech-
nique. Hypertension was defined as a systolic pressure
140 mm Hg. When side-to-side measurements differed,
the higher of the two was used. If an individual reported
hypertension in the questionnaire and the measurement
was lower or higher than 140 mm Hg, hypertension was
defined as “controlled” or “uncontrolled,” respectively.
Smoking history, defined as a lifetime use100 cigarettes,
was further subdivided by daily cigarette consumption
(packs/day), years of smoking, and years from cessation.
Height and weight were used to calculate body mass index.
The greater of the anteroposterior or transverse ultra-
sound-based measurements of the infrarenal abdominal
aorta was used to identify aortic size. AAA was defined by a
diameter of the abdominal aorta 3 cm.
The original data set included 4,153,627 screening
records obtained from 3,770,285 individuals. To distin-
guish an individual with multiple screenings, each individ-
ual was assigned a unique identifier. The investigators had
access only to de-identified “coded” data. The code was not
accessible to the investigators. When multiple screenings
were performed on the same individual, only the mostrecent record with complete information was included. The
analysis excluded individuals where gender, age, and smok-
ing status were missing and those with past AAA repair.
Also excluded were those aged 85 years because this is
generally a frail group with reduced fitness for surgical
intervention where only patients with very large aneurysms
may benefit from screening. The final cohort included
3,056,455 screened individuals.
Statistical analysis. To construct a risk model, the
screened individuals were allocated into two groups using
simple randomization: a data set used for model develop-
ment (50%) and a data set used for validation (50%). In
deriving the model, we first analyzed the univariate associ-
ations between AAA and risk factors using 2 testing.
Variables with a level of significance at P  0.2 were
included in logistic regression analysis. Only significant
variables at P  .05 were left in the final model. The
diagnostic properties of the final model obtained on the
development data set were tested on the validation data set.
The area under the receiver operator curve (ROC) was
calculated to assess predictive ability. From the best fitting
model to predict AAA, we created a simplified scoring
system based on the regression coefficients. To derive the
score, the coefficient of each risk factor was divided by the
absolute value of the lowest coefficient and then rounded to
the nearest integer. For example, if we divide the coefficient
of high cholesterol (0.29) for the coefficient of fruit and
vegetable (0.1), we obtain 3 as the score for high choles-
terol. The total risk score for a person is the sum of the
scores for each individual risk factor. The AAA risk associ-
ated with the total risk score represents the average risk
among all individuals having the same total score. The
scoring system was validated by comparing the predicted
AAA prevalence with the observed prevalence in the valida-
tion data set. The discriminative ability of the scoring
system was evaluated by analysis of the ROC curve. All
statistical analyses were performed using the SAS 9.1 soft-
ware (SAS Institute Inc, Cary, NC).
Estimation of national AAA prevalence. The preva-
lence of risk factors in the generalU.S. populationwas derived
from the National Health and Nutrition Examination Survey
(NHANES, 2003-2006), a cross-sectional survey of the civil-
ian noninstitutionalized U.S. population performed by the
National Center for Health Statistics. NHANES does not
include a test for aortic aneurysms, making it impossible to
estimate AAA prevalence based on NHANES alone. Com-
mon data elements inNHANES and the LLS data set allowed
us to “crosswalk” between the two data sets. These elements
include coronary artery disease, cerebrovascular history,
smoking history (cigarettes/day, years of smoking, years since
quitting), high blood pressure, high cholesterol, diabetes,
family history of coronary artery disease or stroke, frequencyof
exercise, and demographic information. However, family his-
tory of AAA and carotid disease are recorded in the LLS
cohort but not in NHANES, and peripheral arterial disease
(ankle-brachial index0.9) is not available for all years exam-
ined in this study.
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risk model, based only on variables present in both
NHANES and the LLS cohort. This new model was devel-
oped and validated using the development and validation
subsets of the LLS cohort as described above. The discrim-
inative ability of this model was excellent (C statistic 
0.886). A scoring system was then derived and applied to
the NHANES database to calculate the score distribution
in the U.S. population and to estimate the number of
AAAs.
RESULTS
Characteristics of the study population. This analy-
sis includes 3.1 million patients aged 85 and without
previous AAA surgery that were screened by LLS through-
out the United States between 2003 and 2008. The mean
age of the screened cohort was 63.1 years, with 80% of
individuals aged55 years. Althoughmost screenings were
from people of white race (87%), there were also significant
numbers of individuals from other racial and ethnic groups,
including Hispanics, African Americans, Native Americans,
and Asians.
Hypertension and high cholesterol were the most prev-
alent comorbidities, affecting more than half of the cohort,
and 58% of those who had been diagnosed with hyperten-
sion or had been taking antihypertensive medications also
had high blood pressure (HPB) at the screening visit (un-
controlled HBP group). More than half of the cohort
exercised at least once weekly and consumed fruits and
vegetables more than 3 times per week. Two-thirds of
the cohort were overweight or obese (BMI25). Smok-
ers comprised 42.8% of the cohort. Most AAAs were in
smokers and men; however, 19.8% of all AAAs were
found in nonsmokers and 20.7% in women (Table I).
The distribution of maximum aortic diameter by age
among those with AAA was examined (Fig 1). There was
no difference in age distribution between patients with
different size aneurysms.
Risk of AAA. The effect of smoking history on the
risk of AAA was analyzed in detail: it was higher for current
smokers than past smokers, it increased with duration of
smoking (Fig 2, A) and quantity of cigarettes smoked per
day (Fig 2, B), and it declined over time after quitting (Fig
2, C). Consumption of fruit, vegetables, nuts, and fish
showed a strong dose-dependent and inverse correlation
with respect to AAA prevalence in an age-adjusted analysis
(Fig 2, D), whereas red meat and processed or fast food
were associated with increased AAA prevalence, although
this effect did not remain significant in multivariable anal-
ysis. The multivariate logistic regression model for predict-
ing AAA and the resultant scoring system are reported in
Table II.
The discriminative ability of the risk model assessed
by area under the ROC curve was excellent (C statistic 
0.893). The risk factors that remained significantly associ-
ated with AAA were age, gender, high blood pressure,
coronary artery disease, family history of AAA, high
cholesterol, lower extremity peripheral arterial disease,carotid disease, history of a cerebrovascular event, smok-
ing, and being overweight or obese. A negative associa-
tion with AAA was found for certain racial and ethnic
groups, diabetes, exercise at least once per week, and
consumption of fruit, vegetables, and nuts more than
three times per week. The risk attributable to smoking
varied over a wide range: the lowest risk was for individ-
uals who smoked up to a half-pack/day for 10 years
and quit 10 years ago, whereas the highest risk was for
current smokers who had been smoking1 pack/day for
35 years. Correspondingly, the risk score associated
with smoking ranged from 1 to 26. Smoking was among
the strongest predictors of AAA, along with age, gender,
and family history of AAA.
Overall, the scores of different predictors ranged from
4 for Hispanics and Asians to 35 for individuals aged 80
to 84. The total risk score for an individual is obtained by
summing the scores of all the individual risk factors; for
example, a 65-year-old man, past smoker with no other risk
factors, who quit smoking10 years ago and smoked up to
half a pack for no longer than 10 years, has a score of 42.
The relationship between the probability of AAA and the
score is shown in Fig 3, A. The agreement between pre-
dicted and observed AAA was very strong, as shown by the
correlation coefficient (r2  0.98; P  .001). The overall
accuracy of the score is illustrated by the area under the
ROC curve (C statistic  0.842; Fig 3, B).
Prevalence of AAA in the United States. To esti-
mate the prevalence of AAA in the adult population, we
applied to the NHANES data a modified version of the
scoring system including only the common variables be-
tween the LLS and NHANES data sets. Different cut
points or scores for our new scoring system were compared
with the current USPSTF recommendations, and we deter-
mined with each strategy (1) the total number of AAAs
identified, (2) the number of screenings per AAA found,
(3) the prevalence of AAA in the targeted group, and (4)
the number of AAAs found in women, nonsmokers, and
individuals aged 65 (Table III).
We estimated that there are about 1.1 million AAAs
(prevalence, 1.4%) in the population aged 50 to 84. USP-
STF selection criteria (men with smoking history, aged
65-75) capture 29.5% of these AAAs, targeting a cohort
with AAA prevalence of 4.9%. None of the AAAs identified
in this manner, by USPSTF definition, occur in women,
nonsmokers, or people aged65 years. Conversely, the use
of the newly developed scoring system, with a cutoff of 42,
where the system has the best discriminative ability (short-
est distance from the point where sensitivity  1 and
specificity 1), would identify 88.6% of all AAAs, if applied
to a population aged 50 to 84 years, or 59%, if applied to
people 50 to 75 years old. Such a cutoff would include not
only the lowest-risk individuals captured by USPSTF rec-
ommendations (65-year-old male smokers, with no other
risk factors, who smoked 0.5 pack/day and quit 10
years ago: score, 42) but also women, nonsmokers, and
people aged 65.
les am
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calculated if the detection of AAA would be improved
compared with USPSTF criteria. A cutoff at a score of 65 in
Table I. Characteristics of the Life Line Screening cohort
Variables
Without AA
(N 3,033,0
Gender
Females 65.07%
Males 34.93%
Mean age (95% CI) 62.98 (62.97-6
Age groups
55 20.24%
55-59 15.99%
60-64 19.19%
65-69 16.97%
70-74 13.24%
75-79 9.48%
80-84 4.88%
Race/ethnicity
White 86.78%
Hispanics 2.37%
African-American 2.93%
Asian 1.92%
Native American 2.40%
Other race 3.59%
Marital status
Married 68.52%
Single 8.08%
Divorced 8.75%
Widowed 11.83%
Status unknown 2.81%
Smokers 42.47%
Current smokers 10.68%
Past smokers 31.79%
High blood pressure 65.02%
Controlled 19.49%
Uncontrolled 27.09%
Unaware 18.44%
High cholesterol 53.89%
Coronary artery disease 6.72%
Carotid disease 2.48%
Cerebrovascular history 5.47%
Peripheral arterial disease 2.96%
Diabetes 10.69%
Family history
Coronary artery disease 17.66%
Stroke 9.38%
AAA 2.48%
Peripheral arterial disease 2.91%
Body mass index, kg/m2
Underweight, 20 1.18%
Normal, 20-25 30.20%
Overweight, 25 66.73%
Unknown 1.89%
Fast food, 3 times/wk 3.26%
Fruit & vegetables, 3 times/wk 56.00%
Fish, 3 times/wk 7.78%
Nuts, 3 times/wk 27.71%
Meats,a 3 times/wk 20.96%
Exercise,  once/wk 56.00%
AAA, Abdominal aortic aneurysm.
Frequency distribution of demographics, comorbidities and life style variab
aRed and processed meat.the population aged 50 to 75, for example, would captureapproximately the same number of AAAs as the USPSTF
criteria (337,000 vs 334,000) but using fewer ultrasound
studies (16 vs 20 per one AAA identified). Alternatively, a
Screened population
P
With AAA
(N 23,446)
20.66% .0001
79.34% .0001
) 71.10 (71.08-71.20) .0001
1.83% .0001
4.87% .0001
13.26% .0001
20.14% .0001
23.48% .0001
22.07% .0001
14.28% .0001
90.73% .0001
0.86% .0001
1.48% .0001
0.74% .0001
2.93% .0001
3.26% .0060
69.53% .0009
6.48% .0001
6.99% .0001
14.02% .0001
2.96% .1437
80.22% .0001
28.09% .0001
52.14% .0001
81.51% .0001
22.86% .0001
38.61% .0001
20.05% .0001
68.06% .0001
26.69% .0001
9.76% .0001
13.32% .0001
12.56% .0001
13.83% .0001
22.52% .0001
10.01% .0009
7.95% .0001
3.01% .3550
1.20% .8260
23.87% .0001
73.30% .0001
1.63% .0039
2.75% .0001
41.27% .0001
7.04% .0001
23.32% .0001
22.90% .0001
47.59% .0001
ong people diagnosed with and without AAA.A
09)
2.99cutoff at a score of 58, which requires the same number of
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in the population aged 50 to 75, would identify more AAA
patients (480,000) and include women, nonsmokers, and
people aged 65 years.
DISCUSSION
Screening for AAA, followed by surgery, saves lives, as
has been demonstrated in four randomized clinical trials,
with a decrease in AAA-related mortality of about 50%.7-10
However, to design a screening program that is cost-
effective, accurate risk stratification is critical to increase the
likelihood of disease detection. Our study, which includes
3 million individuals, is the largest to date that stratifies
risk for AAA (approximately 25 times the number of pa-
tients included in the next largest study).14 The size of this
cohort has allowed a detailed evaluation of all of the vari-
ables associated with AAA and the definition of a popula-
tion that is truly high-risk.
Smoking is the major environmental risk factor for
AAA, enhancing the chance of developing AAA as well as
the risk of rupture.14-16 With the current criteria for AAA
screening, smoking is treated as a binary variable. However,
we found that AAA had a strong positive association with
quantity and duration of smoking and an inverse associa-
tion with the years after smoking cessation. For example,
the risk of AAA in a current smoker of 10 years is
one-eighth the risk of a smoker of 35 years (Fig 2, A).
Moreover, the risk of AAA in an individual who smokes
0.5 pack/day is one-third the risk of a smoker of 1
pack/day (Fig 2, B). Interestingly, the prevalence of AAA
diminished with the years of abstinence from smoking. It is
therefore not surprising that the inclusion of data regarding
smoking patterns greatly enhanced the accuracy of our risk
model for AAA.
Our findings reinforce the well-known fact that AAA
prevalence is significantly lower in women than in men.
However, despite having one-fifth the number of AAAs as
Fig 1. Distribution of screened people by age groups and abdom-
inal aortic aneurysm (AAA) size. Number of people with AAA
from 3 cm to4 cm, 17,109; from 4 cm to 5 cm, 4093; from 5
cm to 6 cm, 1519; 6 cm and up, 725.men, women constitute approximately one-third of all AAAruptures and almost as many deaths as men.17 No doubt,
screening programs directed exclusively at the male popu-
lation contribute to this phenomenon. With application of
our model to the U.S. population, we have identified a
subset of women with multiple cardiovascular risk factors
where the prevalence of AAA is high and screening is
warranted.
We observed that the consumption of fruit, vegetables,
and nuts, as well as regular exercise, reduced the risk of
AAA. It remains possible that diet and exercise are surro-
gates for other important and unmeasured factors that
contribute to a healthy lifestyle. Nevertheless, these are the
first data available that demonstrate that lifestyle, indepen-
dently from other risk factors, can affect the formation of
AAA. Further reinforcing the role of lifestyle, we found that
a BMI  25 kg/m2 increased the risk of AAA. It is
important to note that the effects of BMI and lifestyle were
small compared with those of age, gender, and smoking.
Our analysis confirms a significant association between
AAA and hypertension, hypercholesterolemia, as well as
pre-existing atherosclerotic occlusive disease in various vas-
cular beds. The influence of elevated blood pressure and
lipids on AAA is substantially less than the influence of these
risk factors on atherosclerotic occlusive disease. This, along
with the negative association of diabetes and AAA, suggests
a very different pathophysiology for these two disease pro-
cesses. Also worth noting is that blood pressure control was
inadequate in 58% of individuals with known hypertension
at the time of the screening event.
Previous reports have shown an inverse association be-
tween African American race and prevalence of AAA.18-20We
confirm this observation and additionally demonstrate that
Hispanics and Asians have a lower prevalence of AAA than
whites after adjusting for all other known risk factors. No
significant differences were noted between Native Ameri-
can and whites. These findings would suggest that dispari-
ties in access to preventive care are not responsible for the
observed differences of AAA prevalence among different
racial and ethnic groups.
Knowledge of the risk factors for AAA is of little prac-
tical value unless this information can be formulated in a
manner that helps the practicing physician determine which
patients should be screened. Accordingly, we integrated
our data into a scoring system to predict the likelihood of an
individual having an AAA. Before being considered useful
in clinical practice, the scoring system will need to be tested
and validated in other well-defined populations. However,
if validated, this prognostic tool could be used by programs
that offer a one-time ultrasound screening benefit to qual-
ified seniors to improve the selection of the target popula-
tion. The criteria currently used by Medicare at the “Wel-
come to Medicare” physical examination are men with a
smoking history or individuals with a family history of
aneurysm disease.21 The scoring system derived in this
study could permit the inclusion of women and nonsmok-
ers and extend the benefit of screening to individuals of
various ages while excluding men who are not truly high-
risk.
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Line Screening cohort are shown for (A) smoking duration, (B) number of cigarettes smoked per day, (C) time
elapsed since quitting, and (D) different dietary habits on the risk of AAA. Reference groups are once per month
or less for food consumption and no smokers for all smoking variables. *Meats: Processed and red meats. The
vertical error bars show 95% confidence intervals.
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the U.S. population, we estimate that there are approxi-
mately 1.1million individuals aged between 50 and 85with
aneurysms. Importantly, a substantial number of women,
nonsmokers, and people 65 with multiple comorbidities
(approximately 569,000 of the 1.1 million) have a risk of
AAA equivalent to or greater than that of 65-year-old male
ever-smokers, the population currently recommended to
have AAA screening by the USPSTF. Many of these at-risk
individuals can be efficiently identified using the scoring
system that has emanated from this analysis. As reported in
Table II. Results of multivariable regression analysis for p
Variable Estimate
Male (vs female) 1.74 .
Age (vs 55)
55-59 1.01 .
60-64 1.68 .
65-69 2.24 .
70-74 2.67 .
75-79 3.02 .
80-84 3.35 .
Race/ethnicity (vs white)
Hispanic 0.37 .
African American 0.33 .
Asian 0.41 .
High blood pressure 0.22 .
Coronary artery disease 0.54 .
Family history of AAA 1.34 .
High cholesterol 0.29 .
Diabetes 0.29 .
Peripheral arterial disease 0.47 .
Carotid disease 0.41 .
Cerebrovascular history 0.16 .
Smoking, packs/day
10 yrs
0.5 0.96 .
0.5-1 1.16 .
1 1.16 .
11-20 yrs
0.5 1.58 .
0.5-1 1.76 .
1 1.79 .
21-35 yrs
0.5 1.99 .
0.5-1 2.08 .
1 2.13 .
35 yrs
0.5 2.19 .
0.5-1 2.42 .
1 2.50 .
Quit smoking
5 yrs ago 0.14 .
5-10 yrs ago 0.39 .
10 yrs ago 0.87 .
Fruit & veg, 3 times/wk 0.10 .
Nuts, 3 times/wk 0.11 .
Exercise, 1 time/wk 0.15 .
BMI 25 kg/m2 0.18 .
BMI, Body mass index; CI, confidence interval; OR, odds ratio.
The model was developed on 50% of the Life Line Screening cohort and vali
model (C statistic) was 0.893. From this model a scoring system was derived
as measured by the C statistic was 0.842.Table III, the proposed system has the theoretic potentialto identify a greater number of aneurysms in a broader
group of individuals and achieve a more favorable ultra-
sound/aneurysm ratio than the existing criteria of men
with a smoking history.
Contrary to the apparent advantage of identifying an-
eurysms in patients aged 65, the value of screening for
AAA in the elderly is less clear. For example, the discovery
of a 3-cm aneurysm in an 83-year-old may be of little
practical importance. One alternative might be to create
screening criteria for individuals 75 years of age with the
goal of identifying 5.5-cm rather than 3-cm aneurysms.
tors of abdominal aortic aneurysm (AAA)
OR 95% CI Score
5.71 5.57-5.85 18
2.76 2.55-3.00 11
5.35 4.97-5.76 17
9.41 8.76-10.12 23
14.46 13.45-15.55 28
20.43 18.99-21.99 31
28.37 26.31-30.59 35
0.69 0.62-0.77 4
0.72 0.66-0.78 3
0.72 0.59-0.75 4
1.25 1.21-1.28 2
1.72 1.69-1.76 6
3.80 3.66-3.95 14
1.34 1.31-1.37 3
0.75 0.73-0.77 3
1.59 1.54-1.65 5
1.51 1.46-1.56 4
1.18 1.14-1.21 2
2.61 2.47-2.74 10
3.19 2.93-3.46 12
3.20 2.88-3.56 12
4.87 4.63-5.12 16
5.79 5.48-6.12 18
6.00 5.66-6.35 19
7.29 6.97-7.64 21
7.99 7.62-8.38 22
8.41 8.57-9.36 22
8.96 8.57-9.36 23
11.19 10.76-11.64 25
12.13 11.66-12.61 26
0.87 0.84-0.912 1
0.68 0.65-0.71 4
0.42 0.41-0.43 9
0.91 0.88-0.92 1
0.90 0.89-0.93 1
0.86 0.85-0.88 2
1.20 1.17-1.22 2
on the other 50%. The area under the receiver operator curve (ROC) of the
cribed in materials and methods. The overall accuracy of the scoring systemredic
P
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
0001
datedAnother alternative could be to avoid rigid age definitions
predictive accuracy no better than chance.
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care physicians to select patients who would benefit from
identification of an aneurysm with the goal of excluding
those with poor longevity or high operative mortality. Of
note, gender is an important companion variable when
considering age limits for screening. The average life ex-
pectancy for women is significantly longer than for men;
thus, identifying aneurysms in a cohort of healthy elderly
women may be of value.
A lower threshold score for screening will identify a
greater number of aneurysms but will require a larger
number of ultrasound studies as well as follow-up testing.
For example, focusing only on the cost of the initial screen-
ing test, a score of42 will allow identification of 680,000
aneurysms in the population aged 50 to 75 but at the
expense of performing 24,907,000 ultrasound studies.
Conversely a score of65will identify roughly half as many
aneurysms but will require only one-fifth the number of
ultrasound studies. The threshold score that is chosen will
be a critical decision that will depend on many factors, with
cost and ultimately cost-effectiveness leading the list.
Our study capitalizes on the unique size of the cohort
of individuals screened by LLS to gain important insights
about the risk of AAA; however, there are limitations. This
cohort consists primarily of self-referred individuals. Indi-
viduals who are concerned with their health and engaged in
taking preventive health measures, such as screening for
vascular disease, typically tend to be from a higher socio-
economic status and may not be representative of the
general population. Moreover, given that the cost of
screening is generally not reimbursed by insurance, this
population is also characterized by their willingness to pay
out of pocket for the screening visit. The potential con-
founding due to self-selection of a specific class of individ-
uals, however, may be reduced by controlling for a number
of variables, such as dietary habits and level of exercise, that
reflect individual socioeconomic status. We also estimated
the prevalence of AAA using frequencies of risk factors
extracted from the NHANES cohort, a sample designed to
be nationally representative. This estimate rests on the
assumption that the associations between AAA and risk
factors found in the LLS cohort are applicable to the
NHANES sample.
A second limitation is that this study relies on self-
reporting of lifestyle variables and some risk factors, which
may lead to misclassification. However, misclassification
would likely bias results toward a lack of significance or
toward elimination of dose-dependent effects, whereas we
observed strong associations and dose responses for health
promoting factors as well as for factors having a negative
impact on health.
CONCLUSIONS
This study provides new and important insights into
the epidemiology of AAA. Our results confirm the impor-
tance of previously known risk factors and identify new
positive and negative predictors such as weight, diet, andFig 3. Validation and discriminative ability of the risk score to
predict abdominal aortic aneurysm (AAA). (A) Observed vs pre-
dicted probability of AAA as a function of total risk score. Predicted
and observed probabilities were calculated using development and
validation subsets (50% each) of the Life Line Screening cohort.
The vertical error bars show 95% confidence intervals for the
observed curve. (B) Receiver operating characteristic (ROC)
curves of AAA risk score (continuous line) and risk score adapted
for National Health and Nutrition Examination Survey
(NHANES; dotted red line). The performance of screening using
cutoff points of 42, 58, and 65 is shown (NHANES version); 42
has the highest discriminative ability (closest point to sensitivity
1 and specificity  1). The diagonal dashed line represents arace. Importantly, we integrate this information into a
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Volume 52, Number 3 Kent et al 547scoring system that may permit clinicians to perform tai-
lored risk estimations in a primary care setting. When we
extrapolated our results to the general population, our
projections showed that a substantial group of high-risk
individuals, including subsets of women, nonsmokers, and
patients aged 65, are excluded from screening using
current criteria. These data offer critical evidence to support
the refinement of AAA screening strategies to more accu-
rately target individuals at risk and motivates validation of
this new screening tool using prospective methods.
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This is an important article. These results will expand our
knowledge, inform future study, and drive government policy.
Critics will point out that the data set is flawed and that the
application of the scoring system to the National Health and
Nutrition Examination Survey (NHANES) data is speculative.
They are correct on both counts, but these criticisms do not negate
the value of this report.
The demographic and lifestyle data reported here consist of
unconfirmed, nonvalidated, self-reported information provided to
a third party by a self-selected population of people sufficiently
motivated by health concerns to pay out of pocket for a heath
screening. Nevertheless, the shear size of this data set provides the
authors with significant statistical power to confirm known associ-
ations, to refine our understanding of specific relationships, and to
identify potential new factors that will benefit from additional
study. The interaction of the quantity and duration of tobacco use
with abdominal aortic aneurysm (AAA) risk could certainly have
been hypothesized, but these effects have not been demonstrated
in multiple, smaller, well-designed studies published previously. In
particular, the negative association of AAA risk with the duration ofThe application of the new scoring scheme to the NHANES
data is indeed a formal exercise and somewhat of a stretch. How-
ever, this “exercise” clearly illustrates the tremendous impact that
initial conditions and selection criteria can have on the costs and
effectiveness of a preventative health service such as AAA screen-
ing. Prospective studies will be needed to confirm the assertions of
the authors’ report, but this analysis will influence the direction of
current government-supported screening programs for AAA as
well as the health promotion activities of private organizations and
payers. There are simply no comparable alternative data available
today to inform public policy in this area.
The reader is correct to be somewhat skeptical of drawing
broad conclusions from an analysis of large data sets collected for
payment or other purposes, but these data and this report clearly
point out the power of large numbers when properly analyzed.
Vascular experts should embrace the appropriate conclusions of
this study and look to creative analysis of other large data sets with
relevance to vascular disease. Personal, institutional, and regional
experiences, although informative, are simply inadequate in a time
when health policy will be driven by cost-benefit and outcomes
analysis applied across populations at risk.
